Pattern and impact of drugs targeted toward toxicity amelioration in patients receiving cancer chemotherapy.

about

Pattern and impact of drugs targeted toward toxicity amelioration in patients receiving cancer chemotherapy.

Item

http://www.wikidata.org/entity/Q49674404

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Pattern and impact of drugs ta ...... receiving cancer chemotherapy.

@en

Pattern and impact of drugs ta ...... receiving cancer chemotherapy.

@nl

type

Item

label

Pattern and impact of drugs ta ...... receiving cancer chemotherapy.

@en

Pattern and impact of drugs ta ...... receiving cancer chemotherapy.

@nl

prefLabel

Pattern and impact of drugs ta ...... receiving cancer chemotherapy.

@en

Pattern and impact of drugs ta ...... receiving cancer chemotherapy.

@nl

P1476

Pattern and impact of drugs ta ...... receiving cancer chemotherapy.

@en

P2093

Prashant Kumar Singh

http://www.w3.org/2001/XMLSchema#string

Shruti Singh

http://www.w3.org/2001/XMLSchema#string

P2860

Biological response modifiers in cancer

A decade of the Fast Track programme

Management and preparedness for infusion and hypersensitivity reactions.

The role of mannitol as a nephroprotectant in patients receiving cisplatin therapy.

Quality of life instruments in oncology.

Adverse drug reaction profile of cisplatin-based chemotherapy regimen in a tertiary care hospital in India: An evaluative study

Hemorrhagic cystitis: A challenge to the urologist.

Social and Economic Implications of Noncommunicable diseases in India

Despite criticism of the FDA review process, new cancer drugs reach patients sooner in the United States than in Europe.

The oral neurokinin-1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting: a multinational, randomized, double-blind, placebo-controlled trial in patients receiving high-dose cisplatin--the Aprepitant Protocol 052 St

P304

23-30

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4103/PICR.PICR_156_16

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29430414

http://www.w3.org/2001/XMLSchema#string

P932

5799948

http://www.w3.org/2001/XMLSchema#string